Evidence map›Paper›PMID 42719689›Full record

ArticleBlockchain in healthcare today2026

Decentralized by Design, Centralized by Necessity: The Blockchain-Surveillance Dilemma.

Vahid Mirzajani Harandi

Abstract read
In one paragraph

Article in Blockchain in healthcare today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vahid Mirzajani HarandiThe Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease surveillance systems face delays in data collection, validation, and reporting at various levels, which undermines early detection and rapid response. Blockchain technology, as a transparent and immutable architecture, can accelerate the flow of epidemiological data and increase trust among actors, but the transition from idea to practical tool requires an analysis of requirements and limitations. This article examines the key challenges of applying blockchain in disease surveillance in two axes: first, governance challenges, data sovereignty, and the inherent conflict of decentralized architecture with epidemiological requirements and privacy laws; second, technical, infrastructural, and operational challenges such as digital identity, interoperability, communication limitations, economic model, and security vulnerabilities. Therefore, the conclusion shows that blockchain can only contribute to transparency and traceability in the form of permissioned/consortium networks with verified identity, and its true effectiveness depends on feasibility studies, piloting, and intelligent combination with data exchange standards and international cooperation.

Indexed as

Blockchaindata governancedisease surveillanceinteroperabilitypermissioned blockchain

Identifiers

PMID42719689
PMCPMC13556146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.